Welcome to CSL Seqirus UK:
We stand on the front line with partners in public health discovering, developing, and delivering pioneering seasonal and pandemic vaccine solutions to safeguard people and communities across the world.
Our Promise to You
Nestled within the epicentre of the UK’s most advanced biotechnology hub, a lot goes on at our state-of-the-art manufacturing facility in Liverpool. In the shadows, we’re quietly working away, driven by our unbreakable promise to help protect public health.
(GBR-NOPR-24-0029 5/23/24)
Report a Suspected Adverse Event
If you experience any side effects from CSL Seqirus products, we encourage you to consult your doctor, pharmacist or caregiver. CSL Seqirus collects adverse drug event/adverse reaction information to monitor product safety and to investigate, evaluate and report adverse event/adverse reaction to relevant regulatory authorities.
To report adverse drug events/adverse reactions, please use the following link for the Yellow Card reporting site: www.mhra.gov.uk/yellowcard or call CSL Seqirus UK Limited at +44 (0) 1748 828816
Email: seqirus@eu.propharmagroup.com
Please note that when you report an adverse
drug event/adverse reaction, we will collect your relevant personal information. For more information on how we process your personal
information please refer to our CSL Global Privacy Policy.